EverQuote (EVER) Shares Skyrocket, What You Need To Know
EverQuote (EVER) shares rose 5.7% after JPMorgan initiated coverage with an Overweight rating and $29 price target. The company reported Q2 revenue of $195.1M, up 25%, and adjusted EBITDA of $30.1M, up 37%. Management guided Q3 revenue to $198-208M and adjusted EBITDA to $28-31M.
How this was made

The 30-second read
Why it matters
The coverage is expected to increase visibility and attract new capital, supporting short‑term price appreciation.
Market read
A fresh Overweight rating from JPMorgan drives a 5.7% pre‑market rally, offering a short‑term trading opportunity.
What to watch
Recent revenue growth slowdown and competitive pressure from larger insurers could temper gains.
Background
EverQuote reported strong Q2 growth earlier, but the current catalyst is fresh analyst coverage.
Ticker impact
JPMorgan initiated coverage with an Overweight rating and $29 price target, prompting a 5.7% pre‑market jump.
Potential further upside of 3‑5% if the target is reinforced.
Overweight rating from a top bank often leads to short‑term buying and may attract institutional flow.
Market effects
Positive signal for the online insurance comparison sector, may lift peers.
US mid‑cap tech/insurtech segment sees modest uplift.
Limited to US‑listed insurtech names.
Counterpoint
The upgrade may be premature; valuation already near the target, limiting upside.
Key entities
- AnalystJPMorgan Chase & Co.
Initiated coverage with Overweight rating and $29 price target.
- CompanyEverQuote
Online insurance comparison platform (NASDAQ: EVER).